Τίτλος:
European League against Rheumatism (EULAR) recommendations and EULAR/American College of Rheumatology criteria - Documenting progress in lupus
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Συγγραφείς:
Aringer, M.
Tektonidou, M.G.
Boumpas, D.
Houssiau, F.
Περιοδικό:
Rheumatology (United Kingdom)
Εκδότης:
Oxford University Press
Λέξεις-κλειδιά:
angiotensin receptor antagonist; anifrolumab; autoantibody; azathioprine; belimumab; beta2 glycoprotein 1 antibody; cardiolipin antibody; dipeptidyl carboxypeptidase inhibitor; DNA; glucocorticoid; hydroxychloroquine; immunomodulating agent; immunosuppressive agent; interferon; interferon receptor; lupus anticoagulant; mycophenolate mofetil; obinutuzumab; prednisolone; rivaroxaban; RNA; RNA binding protein; voclosporin, algorithm; American College of Rheumatology criteria; Article; classification; clinical assessment tool; disease activity; European League Against Rheumatism; human; organization; pathophysiology; phenotype; prophylaxis; proteinuria; rheumatologist; screening; systemic lupus erythematosus; Europe; medical society; practice guideline; systemic lupus erythematosus; United States, Europe; Humans; Lupus Erythematosus, Systemic; Practice Guidelines as Topic; Societies, Medical; United States
DOI:
10.1093/rheumatology/keaa672
